nvp-1402
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 24, 2017 (NCT02897726)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
HSP90AB2P inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nvp-1402
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03340480 | Phase 1 | Dec 12, 2017 | Gachon University, Navipharm Corporation |
| NCT02897726 | Phase 1 | Mar 24, 2017 | Kyungpook University, Navipharm Corporation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Navipharm Corporation | For profit | 2 | 2 | 1 | 2017 |
| Gachon University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Kyungpook University | Academic/Hospital | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1